Private Equity Partners

Name Country
Medicxi Ventures Switzerland
Abingworth LLP UK
Truffle Capital France
Seventure Partners France
Aescap Venture The Netherlands
Alpine Equity Management GmbH Austria
AlpInvest Partners B.V. The Netherlands
Apax Partners Germany
ARAX Capital Partners GmbH Austria
Atlas Venture USA
Austrian Angel Investors Association (AAIA) Austria
aws - Business angel fonds Austria
aws - Equity finder Austria
aws - Founder fund Austria
aws - i2 Business angels Austria
aws - Growth capital fund Austria
BASF Venture Capital GmbH Germany
BioMedPartners AG Switzerland
BNP Paribas Private Equity France
Boehringer Ingelheim Venture Fund Germany
Bpifrance Financement France
Buschier AG Italy
Capricorn Venture Partners NV Belgium
Care Capital, LLC USA
CREATHOR VENTURE Management GmbH Germany
Delta Partners Ireland
dievini Hopp BioTech holding GmbH & Co. KG Germany
DPE Deutsche Private Equity GmbH Germany
DSM Venturing B.V. The Netherlands
Earlybird VC Management GmbH & Co. KG Germany
EcoR1 Capital, LLC USA
ECOS Private Equity GmbH Austria
Edmond de Rothschild Investment Partners France
EMBL Ventures GmbH Germany
Endeavour Vision SA Switzerland
Entrepreneurs Fund Management LLP UK
Forbion Capital Partners Germany
GCP Gamma Capital Partners Beratungs- & Beteiligungs GmbH Austria
Gilde Healthcare Partners The Netherlands
Gimv NV Germany
Global Life Science Ventures GmbH (GLSV) Germany
HBM Partners AG Switzerland
High-Tech Gründerfonds Management GmbH (HTFG) Germany
Horizonte Venture Management GmbH Austria
i4g Investment GmbH Austria
idinvest Partners France
Index Ventures Switzerland
IPF Partners Luxembourg
IPO Beteiligungs-Management AG Austria
Johnson & Johnson Innovation - JJDC, Inc. USA
LSP - Life Sciences Partners Germany
Lundbeck Foundation Denmark
MedVenture Partners GmbH Germany
Merck Ventures (M Ventures) Germany
Metabasis Management GmbH Austria
MIG Verwaltungs AG Germany
MP Healthcare Venture Management, Inc. (MPH) USA
MPM Capital USA
Mulligan BioCapital GmbH Germany
MVM Life Science Partners LLP UK
Norgine Ventures Management Limited UK
Novartis Venture Fund (NVF) Switzerland
Novo Holdings Denmark
Omnes capital France
OrbiMed Advisors LLC USA
Peppermint VenturePartners GmbH Germany
PONTIS Capital GmbH Austria
PP Capital AG Austria
Quantensprung Beteiligungen GmbH Austria
Roche Venture Fund Switzerland
SHS Gesellschaft für Beteiligungsmanagement mbH Germany
Siemens Venture Capital GmbH (SVC) Germany
Smart Capital GmbH Austria
Sofinnova Partners France
SR One UK
Star Ventures Germany
Sunstone Capital A/S Denmark
Syngenta Ventures Switzerland
Takeda Ventures, Inc. USA
Tavistock Life Sciences LLC USA
tecnet equity NÖ Technologiebeteiligungs-Invest GmbH Austria
The BioScience Ventures Group AG (BSVG) Germany
TVM Capital GmbH Germany
V+ Beteiligungs GmbH Germany
Ventech Germany
Vesalius Biocapital Partners Sàrl Luxembourg
Vivo Capital USA
Wellington Partners Germany
Ysios Capital Partners Spain
Zcube S.r.l. - Zambon Research Venture Italy
Syncona Partners LLP UK
Pierre Fabre Fund for Innovation France
Invest Unternehmensbeteiligungs AG Austria
Taiho Ventures, LLC USA
B&C Innovation Investments GmbH Austria
Venionaire Capital Austria
APEX Ventures GmbH Austria
UNIQA Ventures Austria
Advent France Biotechnology France
Arix Bioscience UK
Athyrium Capital USA
BB Pureos Bioventures Switzerland
Bioqube Ventures Belgium
BOM - Brabantse Ontwikkelings Maatschappij The Netherlands
Bracknor IG UAE
Caixa Capital Risc Spain
Capital Grand Est France
coparion GmbH & Co. KG Germany
CTI Life Sciences Canada
EIB - European Investment Bank Luxembourg
Europe Offering France
EIF - European Investment Fund Luxembourg
GO CAPITAL France
HealthCare Royalty Partners UK
Image Analysis Group (IAG) UK
Industrifonden Sweden
Korys Investments Belgium
Kreos Capital UK
LBBW Venture Capital GmbH Germany
Mitsui Global Investment USA
PMV Belgium
Seroba Life Sciences Ireland
Sofinnova Ventures USA
SOTIO a.s. - PPF Biotech Venture Investing Czech Republic
V-Bio Ventures Belgium
Xeraya Capital Malaysia
Pfizer Ventures USA

This list is not exhaustive. LISAvienna accepts no liability for potential mistakes.

Please contact us at office(at)LISAvienna.at to add a private equity fund or to update an entry.

Contact us for an individual account on Private Equity

Jürgen Fuchs
Technology Expert Biotech & Pharma
T +43 1 501 75 547
M +43 664 548 67 28
fuchs@LISAvienna.at
Martin Mayer
Technology Expert Medtech
T +43 1 501 75 235
M +43 664 8846 72 09
mayer@LISAvienna.at